A unit inside of Johnson and Johnson focused on bone health announced an acquisition this morning that will allow them to help heal patient's broken bones with 3d printing.
The technology from Tissue Regeneration Systems, Inc. (TRS) will now be a part of DePuy Synthes Products, Inc, an arm of J&J, and is implemented by creating implantable bone-like components that absorb inside the body naturally to heal broken bones and other bone deformities.
"We are systematically investing in building a pipeline of 3D printed products," said Ciro Römer, Company Group Chairman of DePuy Synthes. "The TRS technology, which will be added to the DePuy Synthes Trauma Platform, is the latest example of how we are working toward developing next-generation technologies that transform healthcare delivery with individualized solutions for patients."
Top orthodpedic hospitals across the country - including top tier organizations such as the Hospital for Special Surgery in New York - are using 3d printing to offer customized health care solutions to their patients instead of standardized products.
If you need a knee implant, wouldn't you rather have an implant designed specifically for your body as opposed to one built for thousands of other people?
"The acquisition of the TRS technology by DePuy Synthes is testament to our ability to identify and work collaboratively with promising early-stage companies and entrepreneurs to accelerate bringing innovative new products to market," said Robert G. Urban, PhD, Global Head, Johnson & Johnson Innovation. "We are excited at the potential this technology holds to help improve patient outcomes."